Literature DB >> 3117445

Ovulation of a single dominant follicle during treatment with low-dose pulsatile follicle stimulating hormone in women with polycystic ovary syndrome.

D W Polson1, H D Mason, M B Saldahna, S Franks.   

Abstract

Ten women with clomiphene-resistant chronic anovulation associated with polycystic ovary syndrome were treated with purified urinary FSH (urofollitrophin). The gonadotrophin was given s.c. by pulsatile infusion pump starting at a low dose (1 ampoule or 75 U/d) and increasing by 37.5 U/d at weekly stages in an attempt to induce ovulation of a single follicle. Seventy percent of the 33 cycles were ovulatory and in 18 of these (78%) a single dominant follicle developed and ovulated. Each of the 10 women ovulated when the optimum dose was reached and five of these women became pregnant. The maximum dose of FSH in uni-ovulatory cycles was 150 U/d or less. Endogenous LH concentrations which were raised at the onset of treatment were suppressed in the late follicular phase. The rate of follicular growth and gonadal steroid concentrations were consistent with those observed in spontaneous ovulatory cycles. This study demonstrates that by using low-dose gonadotrophin therapy it is possible to find the 'threshold' dose of FSH to promote maturation of a single dominant follicle. The high rate of ovulation and pregnancy suggest that this approach is of practical importance in treatment of infertile patients with polycystic ovaries.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3117445     DOI: 10.1111/j.1365-2265.1987.tb00778.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  7 in total

1.  Primary and secondary amenorrhoea.

Authors:  S Franks
Journal:  Br Med J (Clin Res Ed)       Date:  1987-03-28

2.  Recombinant HCG for triggering ovulation increases the rate of mature oocytes in women treated for ICSI.

Authors:  A Farrag; A Costantini; C Manna; G Grimaldi
Journal:  J Assist Reprod Genet       Date:  2008-10-17       Impact factor: 3.412

3.  Recombinant follicle-stimulating hormone (follitropin alfa) versus purified urinary follicle-stimulating hormone in a low-dose step-up regimen to induce ovulation in Japanese women with anti-estrogen-ineffective oligo- or anovulatory infertility: results of a single-blind Phase III study.

Authors:  Yuji Taketani; Eduardo Kelly; Yasunori Yoshimura; Hiroshi Hoshiai; Minoru Irahara; Hideki Mizunuma; Hidekazu Saito; Kazumichi Andoh; Takumi Yanaihara
Journal:  Reprod Med Biol       Date:  2010-02-23

4.  Ovulation induction with minimal dose of follitropin alfa: a case series study.

Authors:  Isidoro Bruna-Catalán; Marco Menabrito
Journal:  Reprod Biol Endocrinol       Date:  2011-10-24       Impact factor: 5.211

Review 5.  The management of infertility associated with polycystic ovary syndrome.

Authors:  Roy Homburg
Journal:  Reprod Biol Endocrinol       Date:  2003-11-14       Impact factor: 5.211

Review 6.  Optimal management of subfertility in polycystic ovary syndrome.

Authors:  Joshua J Berger; G Wright Bates
Journal:  Int J Womens Health       Date:  2014-06-13

Review 7.  Naturally Occurring and Experimentally Induced Rhesus Macaque Models for Polycystic Ovary Syndrome: Translational Gateways to Clinical Application.

Authors:  David H Abbott; Jeffrey Rogers; Daniel A Dumesic; Jon E Levine
Journal:  Med Sci (Basel)       Date:  2019-11-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.